2011 Journal Article Recurrent readmissions in medical patients: A prospective studyMudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811 |
2011 Journal Article Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosisBarras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x |
2010 Journal Article Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional developmentNorris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a |
2010 Journal Article Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrationsBarras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846 |
2010 Journal Article Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international surveyBarras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x |
2010 Journal Article Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMartin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24. |
2010 Journal Article Routine plasma anti-Xa monitoring is required for low-molecular-weight heparinsAl-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000 |
2009 Journal Article Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising eventsBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x |
2009 Journal Article Myalgia in patients on high-dose and low-to-moderate dose statin therapyGujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x |
2009 Journal Article Preliminary results of a therapeutic drug monitoring survey in AustralasiaNorris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167 |
2008 Journal Article Individualized compared with conventional dosing of enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399 |
2008 Journal Article Individualised vs conventional enoxaparin dosingBarras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1), 77-81. doi: 10.1002/j.2055-2335.2008.tb00803.x |
2007 Journal Article Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field testsGardner, A. Scott, Martin, James C., Martin, David T., Barras, Martin and Jenkins, 47517 (2007). Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests. European Journal of Applied Physiology, 101 (3), 287-292. doi: 10.1007/s00421-007-0498-4 |
2007 Journal Article General practitioner referral letters: are we getting the full picture?Toleman, J. and Barras, M. (2007). General practitioner referral letters: are we getting the full picture?. Internal Medicine Journal, 37 (7), 510-511. doi: 10.1111/j.1445-5994.2007.01416.x |
2007 Journal Article Pharmacists investigating adverse penicillin responses - Pilot StudyRoberts, Jason A., Hsu, Millie, Allen, Karen, Willis, Jennifer and Barras, Michael (2007). Pharmacists investigating adverse penicillin responses - Pilot Study. Journal of Pharmacy Practice and Research, 37 (3), 200-203. doi: 10.1002/j.2055-2335.2007.tb00744.x |
2006 Journal Article Are patients on long-term corticosteroids receiving bone loss therapy?Rofail, Serena and Barras, Michael A. (2006). Are patients on long-term corticosteroids receiving bone loss therapy?. Journal of Pharmacy Practice and Research, 36 (1), 29-31. doi: 10.1002/j.2055-2335.2006.tb00882.x |
2005 Journal Article Patients' understanding of drug allergy and documentation: Is there a link?Sim, Lily, Barras, Michael and Cottrell, Neil (2005). Patients' understanding of drug allergy and documentation: Is there a link?. Journal of Pharmacy Practice and Research, 35 (4), 276-278. doi: 10.1002/j.2055-2335.2005.tb00362.x |
2005 Journal Article Teaching people with Parkinson's disease about their medicationO'Maley, Karen, O'Sullivan, John, Wollin, Judy, Barras, Michael and Brammer, Jillian (2005). Teaching people with Parkinson's disease about their medication. Nursing Older People, 17 (1) doi: 10.7748/nop2005.03.17.1.14.c2357 |
2004 Journal Article Effective conference presentationsLum, E. and Barras, M.A. (2004). Effective conference presentations. Journal of Pharmacy Practice and Research, 34 (2), 157-158. |